Weifa has signed a 5-year distribution agreement with the Fysioline Group (Finland). The agreement covers several of Weifa’s most recently launched products within the pain category, and can be extended to include additional products. Fysioline will sell, market, and distribute the products on an exclusive basis in the Finnish market under Weifa’s brand names. The first product will be launched towards the end of 2016.
Fysioline is the leading Finnish wellness and fitness company, and is currently expanding its pharma division. The company has several market-leading brands within the pain and joint/muscle categories, sold through Pharmacies.
“We are very happy to have signed our first collaboration agreement for the Finnish market. This represents an important first step in building a Nordic platform for our established Weifa brands. The first two products represent a combined annual peak-sales potential (3-5 years from launch) for Weifa in the high single-digit million range (NOK). As announced in June 2015, we aim to expand our business in the Nordic region through different types of partnerships and acquisitions. In December 2015, we acquired Asan and Sana with sales in Norway and Sweden, and now we have made our first move into Finland”, says Kathrine Gamborg Andreassen (CEO Weifa).
For further information, please contact:
Kathrine Gamborg Andreassen
+47 95 17 86 80
About Weifa:Weifa is Norway's leading Consumer health company. Weifa supplies pharmaceutical products and lifestyle products that address the essential needs of consumers, customers and professional partners. The Company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux, and is also present in other key areas such as intimate care, dietary supplements and treatment for colds and respiratory problems. Weifa is listed on the Oslo Stock Exchange and has its head office in Oslo. In 2015, the Group had a turnover of approximately NOK 332m (after adjusting for the divestment of the B2B business). The company currently has approximately 30 employees.
About Fysioline: TheFysioline Group is the leading provider of fitness and healthcare products and services in Finland. Its chain of fitness and wellness centers holds a market leading position within the areas of physiotherapy, rehabilitation and fitness, and the company is also the dominating supplier of equipment for these sectors. The Pharma division has developed several market leading brands within the pain and joint/muscle categories, including the IcePower product range, which is exported to some 50 countries. Fysioline’s range of Medical Devices and drug products is actively marketed to health-care professionals and consumers around Finland, and is sold exclusively through Pharmacies. The Group was founded in 1990, and is privately held. Total Group revenues amounted to some Euro 40 million in 2015.